Patients with this result are at high risk for adverse outcomes related to prescription stimulant use (for example: methylphenidate) and are likely to meet DSM-5 criteria for a Stimulant Use Disorder.
Display Title
Stimulant Risk Level: High Risk for Stimulant Use Disorder
Tool Type
Drugs of Abuse
Risk Level
High
Additional Resources
Stimulant Use Resources
General Resources
- Screening, Brief Intervention & Referral to Treatment Training Manual – Yale School of Medicine
- Behavioral Health Treatment Services Locator – SAMHSA
- Motivational Interviewing Skills Practice – NIDA
- OARS Essential Communication Techniques – Oregon.gov
- Principles of Drug Addiction Treatment: A Research-Based Guide (3rd ed.) - Behavioral Therapies – NIDA
Suggested Action
The suggested intervention for this group is further assessment and treatment for those who are found to have a Stimulant Use Disorder.
- Assess further through a clinical interview.
- Questions from the DSM-5 Stimulant Use Disorder criteria can be used as a guide.
- Express concern and recommend cessation.
- Use the FRAMES components and motivational interviewing techniques (see references for specific resources) to encourage engagement in treatment.
- Make a specific plan, including strategies for reducing health consequences of substance use.
- Offer a referral to counseling or a treatment program for SUD and any co-occurring problems, such as depression, that may be driving substance use.
- Review any prescribed medications to identify those that may be affected by other substance use.
- When applicable, address the risks of diversion, non-medical use, and misuse of prescription stimulants.
- Educate patient on risks associated with using stimulants with heroin or combining stimulants with alcohol or other drugs.
- Advise not to use drugs and drive.
- Arrange follow-up.